PCA
BCRX icon

Pallas Capital Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Pallas Capital Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$126K Sell
14,079
-5,718
-29% -$51.2K ﹤0.01% 786
2025
Q1 		$148K Buy
+19,797
New +$148K 0.01% 697